Flavell; Richard A.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Flavell; Richard A..The latest application filed is for "nanolipogel vehicles for controlled delivery of different pharmaceutical agents".

Company Profile

6.19.23

Flavell; Richard A. - Guillford CT
Flavell; Richard A. - Guilford CT
Flavell; Richard A. - Guildford CT
Flavell; Richard A. - Killingworth CT

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Nanolipogel Vehicles For Controlled Delivery Of Different Pharmaceutical Agents App 20220031617 - Fahmy; Tarek M. ; et al.	2022-02-03
Nanolipogel vehicles for controlled delivery of different pharmaceutical agents Grant 11,173,119 - Fahmy , et al. November 16, 2	2021-11-16
Genetically Modified Non-human Animals And Methods Of Use Thereof App 20200229410 - Herndler-Brandstetter; Dietmar ; et al.	2020-07-23
Vehicles For Controlled Delivery of Different Pharmaceutical Agents App 20200179283 - Fahmy; Tarek M. ; et al.	2020-06-11
Nanolipogel vehicles for controlled delivery of different pharmaceutical agents Grant 10,603,276 - Fahmy , et al.	2020-03-31
Genetically modified non-human animals and methods of use thereof Grant 10,561,126 - Herndler-Brandstetter , et al. Feb	2020-02-18
Compositions And Methods For Diminishing An Immune Response App 20190211307 - FLAVELL; Richard A. ; et al.	2019-07-11
Compositions and methods for diminishing an immune response Grant 10,260,042 - Flavell , et al.	2019-04-16
Genetically modified non-human animals and methods of use thereof Grant 10,123,518 - Herndler-Brandstetter , et al. November 13, 2	2018-11-13
Genetically Modified Non-human Animals And Methods Of Use Thereof App 20180295820 - Herndler-Brandstetter; Dietmar ; et al.	2018-10-18
Vehicles For Controlled Delivery of Different Pharmaceutical Agents App 20180200336 - Fahmy; Tarek M. ; et al.	2018-07-19
Compositions And Methods For Diminishing An Immune Response App 20180119099 - FLAVELL; Richard A. ; et al.	2018-05-03
Human SIRP.alpha. transgenic mice and their methods of use Grant 9,839,208 - Flavell , et al. December 12, 2	2017-12-12
Nanolipogel vehicles for controlled delivery of different pharmaceutical agents Grant 9,610,250 - Fahmy , et al. April 4, 2	2017-04-04
Human SIRPa Transgenic Animals and Their Methods of Use App 20170027140 - Flavell; Richard A. ; et al.	2017-02-02
Genetically Modified Non-human Animals And Methods Of Use Thereof App 20160295844 - Herndler-Brandstetter; Dietmar ; et al.	2016-10-13
Human SIRPAalpha transgenic animals and their methods of use Grant 9,402,377 - Flavell , et al. August 2, 2	2016-08-02
Targeting TGF-.beta. as a therapy for Alzheimer's disease Grant 9,095,126 - Flavell , et al. August 4, 2	2015-08-04
Compositions And Methods For Diminishing An Immune Response App 20150132272 - Flavell; Richard A. ; et al.	2015-05-14
Vehicles for Controlled Delivery of Different Pharmaceutical Agents App 20150064265 - Fahmy; Tarek M. ; et al.	2015-03-05
Compositions and Methods for Assessing and Treating Inflammatory Diseases and Disorders App 20140377278 - Elinav; Eran ; et al.	2014-12-25
Human SIRPAalpha Transgenic Animals and Their Methods of Use App 20130340105 - Flavell; Richard A. ; et al.	2013-12-19
Jnk3 Modulators And Methods Of Use App 20120240247 - Davis; Roger J. ; et al.	2012-09-20
Targeting TGF-beta as a Therapy for Alzheimer's Disease App 20110136892 - Flavell; Richard A. ; et al.	2011-06-09
Caspase-9 deficient animals and the use thereof App 20090205062 - Kuida; Keisuke ; et al.	2009-08-13
Genetically altered mice deficient in functional caspase-9 Grant 7,323,616 - Kuida , et al. January 29, 2	2008-01-29
IRAK-M is a negative regulator of toll-like receptor signaling App 20060188933 - Flavell; Richard A. ; et al.	2006-08-24
JNK3 modulators and methods of use Grant 6,943,000 - Davis , et al. September 13, 2	2005-09-13
Universal donor cells Grant 6,916,654 - Sims , et al. July 12, 2	2005-07-12
Compositions and methods relating to glucose metabolism, weight control, and food intake Grant 6,861,405 - Desir , et al. March 1, 2	2005-03-01
Caspase-9 deficient animals and the use thereof App 20040255343 - Kuida, Keisuke ; et al.	2004-12-16
B. burgdorferi polypeptides Grant 6,716,591 - Flavell , et al. April 6, 2	2004-04-06
RIP2: a mediator of signaling in the innate and adaptive immune systems App 20030224388 - Flavell, Richard A. ; et al.	2003-12-04
IRAK-M is a negative regulator of toll-like receptor signaling App 20030157539 - Flavell, Richard A. ; et al.	2003-08-21
Jnk3 Modulators And Methods Of Use App 20030023990 - DAVIS, ROGER J. ; et al.	2003-01-30
Universal donor cells Grant 6,100,443 - Sims , et al. August 8, 2	2000-08-08
Universal donor cells Grant 5,705,732 - Sims , et al. January 6, 1	1998-01-06
Flagellin-based polypeptides for the diagnosis of lyme disease Grant 5,618,533 - Flavell , et al. April 8, 1	1997-04-08

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.